Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Ezetrol
Active Ingredient: Ezetimibe 10mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Schering-Plough Limited, Singapore
Schering-Plough Products Inc, Las Piedras, Puerto Rico
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 10mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 20mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 40mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 80mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Dated this 20th day of March 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).